A Two Stage ES Cell Differentiation Screen

Vanderbilt researchers have identified compounds that selectively differentiate stem cells into cardiomyocytes by perturbing key pathways. Medicinal chemistry is currently underway to develop lead compounds that maybe used for the treatment of damaged cardiac muscle.
Inventors: 
Charles HongAntonis HatzopoulosCraig LindsleyJijun HaoCorey Hopkins
Licensing manager: 
Mike Villalobos

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter